Related Experiment Video
Updated: Apr 15, 2026
10:04
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
19.4K
Tuberculosis in Poland in 2023
Maria Joanna Korzeniewska-Koseła1, Adam Nowiński1
1Zakład Epidemiologii i Organizacji Walki z Gruźlicą, Instytut Gruźlicy i Chorób Płuc.
Przeglad Epidemiologiczny
|April 14, 2026
Summary
Tuberculosis remains a significant public health issue in Poland, with notification rates increasing by 3.5% in 2023. While multidrug-resistant tuberculosis (MDR-TB) and childhood cases are lower than in EU/EEA countries, overall mortality has not decreased.
Area of Science:
- Epidemiology
- Public Health
- Infectious Diseases
Background:
- Tuberculosis (TB) is a major global health concern, affecting millions worldwide.
- In 2023, TB continued to be a significant public health challenge within the European Union (EU) and European Economic Area (EEA).
Purpose of the Study:
- To conduct an epidemiological analysis of tuberculosis in Poland for the year 2023.
- To compare the tuberculosis situation in Poland with that of other EU and EEA countries.
Main Methods:
- Data were sourced from the National Tuberculosis Register, Statistics Poland, and the NIZP PZH - PIB.
- Analysis included registered cases, drug susceptibility testing, mortality data, and TB as an AIDS-defining condition.
- International comparisons utilized a European Centre for Disease Prevention and Control (ECDC) report for EU/EEA countries.
Main Results:
- Poland registered 4,436 tuberculosis cases in 2023, with a notification rate of 11.3 per 100,000 population.
- Pulmonary TB constituted 96.1% of cases; 7.9% of cases were of foreign origin, and multidrug-resistant TB (MDR-TB) was found in 3.1% of tested patients.
- Notification rates increased with age, with higher rates in men. Tuberculosis caused 483 deaths.
Conclusions:
- Tuberculosis notification rates in Poland increased by 3.5% compared to 2022.
- Poland reported a lower proportion of MDR-TB and childhood TB cases (<14 years) than the EU/EEA average.
- Tuberculosis mortality in Poland showed no decrease in 2023.
Related Concept Videos
01:28Pulmonary Tuberculosis II
2.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.3K
01:29Pulmonary Tuberculosis I
1.5K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.5K
01:28Pulmonary Tuberculosis V
926
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
926
01:31Pulmonary Tuberculosis III
1.6K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.6K
01:26Pulmonary Tuberculosis IV
751
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
751
01:14Atypical Pneumonia
64
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
64